180 related articles for article (PubMed ID: 1602370)
1. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.
Studenberg SD; Brouwer KL
J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370
[TBL] [Abstract][Full Text] [Related]
2. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
Brouwer KL; Jones JA
J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
[TBL] [Abstract][Full Text] [Related]
3. Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat.
Brouwer KL
Drug Metab Dispos; 1993; 21(6):1129-33. PubMed ID: 7905395
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism for the enhancement of acetaminophen hepatotoxicity by phenobarbital.
Douidar SM; Ahmed AE
J Pharmacol Exp Ther; 1987 Feb; 240(2):578-83. PubMed ID: 3806412
[TBL] [Abstract][Full Text] [Related]
6. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats.
Ghanem CI; Ruiz ML; Villanueva SS; Luquita MG; Catania VA; Jones B; Bengochea LA; Vore M; Mottino AD
J Pharmacol Exp Ther; 2005 Dec; 315(3):987-95. PubMed ID: 16109740
[TBL] [Abstract][Full Text] [Related]
7. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.
Studenberg SD; Brouwer KL
J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679
[TBL] [Abstract][Full Text] [Related]
8. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
Savina PM; Brouwer KL
Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
[TBL] [Abstract][Full Text] [Related]
9. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation and biliary excretion of acetaminophen in rats.
Hjelle JJ; Klaassen CD
J Pharmacol Exp Ther; 1984 Feb; 228(2):407-13. PubMed ID: 6694118
[TBL] [Abstract][Full Text] [Related]
11. Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats.
Tuntaterdtum S; Chaudhary IP; Cibull M; Robertson LW; Blouin RA
Toxicol Appl Pharmacol; 1993 Dec; 123(2):219-25. PubMed ID: 8248929
[TBL] [Abstract][Full Text] [Related]
12. Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentration of acetaminophen-glutathione adducts.
Manautou JE; Tveit A; Hoivik DJ; Khairallah EA; Cohen SD
Toxicol Appl Pharmacol; 1996 Sep; 140(1):30-8. PubMed ID: 8806867
[TBL] [Abstract][Full Text] [Related]
13. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
Watkins JB
J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
[TBL] [Abstract][Full Text] [Related]
14. Hepatic disposition of acetaminophen and metabolites. Pharmacokinetic modeling, protein binding and subcellular distribution.
Studenberg SD; Brouwer KL
Biochem Pharmacol; 1993 Aug; 46(4):739-46. PubMed ID: 8363647
[TBL] [Abstract][Full Text] [Related]
15. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
Gregus Z; Madhu C; Goon D; Klaassen CD
Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
[TBL] [Abstract][Full Text] [Related]
16. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
Chaudhary IP; Tuntaterdtum S; McNamara PJ; Robertson LW; Blouin RA
J Pharmacol Exp Ther; 1993 Jun; 265(3):1333-8. PubMed ID: 8510012
[TBL] [Abstract][Full Text] [Related]
17. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
Gregus Z; Madhu C; Klaassen CD
Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro biotransformation of theobromine by phenobarbital- and 3-methylcholanthrene-inducible cytochrome P-450 monooxygenases in rat liver. Role of thiol compounds.
Shively CA; Vesell ES
Drug Metab Dispos; 1987; 15(2):217-24. PubMed ID: 2882982
[TBL] [Abstract][Full Text] [Related]
19. Biliary excretion of iopanoate glucuronide by the rat.
Cooke WJ; Cooke L
Drug Metab Dispos; 1977; 5(4):368-76. PubMed ID: 19216
[TBL] [Abstract][Full Text] [Related]
20. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
